HomeVTGN • NASDAQ
Vistagen Therapeutics Inc
add
$3.04
4.83%
After Hours:(0.00%)0.00
$3.04
Closed: Sep 18, 7:18:47 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 244.00K | 190.48% |
Operating expense | 16.05M | 31.38% |
Net income | -15.10M | -40.64% |
Net profit margin | -6.19K | 51.58% |
Earnings per share | -0.47 | -34.29% |
EBITDA | -15.76M | -30.31% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 63.18M | -41.70% |
Total assets | 68.92M | -39.30% |
Total liabilities | 12.16M | 39.04% |
Total equity | 56.77M | — |
Shares outstanding | 30.68M | — |
Price to book | 1.49 | — |
Return on assets | -51.56% | — |
Return on capital | -60.31% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -15.10M | -40.64% |
Cash from operations | -18.85M | -73.39% |
Cash from investing | -788.00K | 85.59% |
Cash from financing | 1.49M | 1,590.91% |
Net change in cash | -18.15M | -11.68% |
Free cash flow | -13.27M | -114.53% |
Previous close
$2.90
Day range
$2.90 - $3.06
Year range
$1.90 - $3.88
Market cap
90.46M USD
Avg Volume
543.39K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1998
Headquarters
Website
Employees
57